Eversept Partners’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
Eversept Partners's OCDX Position: Q2 2022 in Review
Eversept Partners sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2022, closing a stake of 445,059 shares — an estimated $8.3M sold.
Eversept Partners first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $29.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.
- Eversept Partners reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2022 after selling out during the quarter.
- Eversept Partners sold 445,059 Ortho Clinical Diagnostics Holdings shares in Q2 2022, an estimated $8.3M.
- Eversept Partners first reported a position in Ortho Clinical Diagnostics Holdings in Q1 2021 and held it in 5 quarters.
- Eversept Partners's Ortho Clinical Diagnostics Holdings position peaked at $29.9M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2022.
Based on Eversept Partners's 13F filing for Q2 2022, filed 15 Aug 2022.